We have attentively read the article by Szatan et al. entitled "Ultraslow thrombolysis for subacute mitral prosthetic valve thrombosis" [1] We appreciate the authors for the successful treatment of mitral prosthetic valve thrombosis using low-dose and ultraslow infusion of tissue plasminogen activator (t-PA).On the other hand, we believe that there are several major
No takes yet. Share an insight, caveat, or question.
Güner et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: